Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Empower Clinics receives approval from Health Canada to see at home Saliva Collection Kits

Empower Clinics receives approval from Health Canada to see at home Saliva Collection Kits

Empower Clinics CEO Steven McAuley joined Steve Darling from Proactive to bring news the company has received approval from Health Canada to proceed under the original Device Class I authorization for Kai Care COVID-19 At-Home Saliva Collection Kit.

McAuley told Proactive the company was selling already in Canada but paused in September to participate in a review with Health Canada. That review is complete and will soon resume Canadian sales. The Company is preparing reactivation steps such as updating the product labelling, instructions and an e-commerce site based on the revised framework from Health Canada.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK